Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
7
NCT04608812
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 2, 2021
Completion: Feb 27, 2023